Practical considerations in the administration of intravenous vasoactive drugs in the critical care setting: Part II—How safe is our practice?
- 作者Amanda Morrice; Emma Jackson; Sarah Farnell
- 卷第20卷
- 期第4期
- 印刷ISSN0964-3397
- 文件大小242.26KB
- 发表时间2004
- DOI10.1016/j.iccn.2004.04.008
- 页码183-189
Practical considerations for administration of cisplatin (Platinol) in the outpatient settingFrogge, Margaret Hansen · 1987
SOME PRACTICAL CONSIDERATIONS IN THE ADMINISTRATIVE CONTROL OF EPIDEMIC POLIOMYELITISEMERSON, HAVEN · The American Journal of the Medical Sciences · 1917
Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunctionWidemann, Brigitte C. · Pediatric Blood & Cancer · 2015
Methodological and practical considerations for studying the effects of change in ward administration on staff and patientsAthan Karras; Sister Joan Maria Upjohn; Mark Lefton · 1963
Practical considerations in the administration of intravenous vasoactive drugs in the critical care setting: Part II—How safe is our practice?Amanda Morrice; Emma Jackson; Sarah Farnell · 2004
Practical considerations in the administration of intravenous vasoactive drugs in the critical care setting: the double pumping or piggyback technique?part oneTRIM, J · Intensive and Critical Care Nursing · 2004
Current Evidence on Safety and Practical Considerations for Administration of Sublingual Allergen Immunotherapy (SLIT) in the United StatesEpstein, Tolly G.; Calabria, Christopher; Cox, Linda; Dreborg, Sten · The Journal of Allergy and Clinical Immunology: In Practice · 2016